Rebecca S. Saleeb

Rebecca S. Saleeb

Auto-generated profile, based on publicly available information

Rebecca S. Saleeb

EaStCHEM School of Chemistry The University of Edinburgh Edinburgh EH9 3FJ UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
FMFabio de Moliner
Fabio de Moliner
ZKZuzanna Konieczna
Zuzanna Konieczna
LMLorena Mendive‐Tapia
Lorena Mendive‐Tapia
RSRebecca S. Saleeb
Rebecca S. Saleeb
KMKatie Morris
Katie Morris
MVMarc Vendrell
Marc Vendrell
The multiple applications of super‐resolution microscopy have prompted the need for minimally invasive labeling strategies for peptide‐guided fluorescence imaging. Many fluorescent reporters display limitations (e.g., large and charged scaffolds, non‐specific binding) as building blocks for the construction of fluorogenic peptides. Herein we have built a library of benzodiazole amino acids and systematically examined them as reporters for background‐free fluorescence microscopy. We have identified amine‐derivatized benzoselenadiazoles as scalable and photostable amino acids for the straightforward solid‐phase synthesis of fluorescent peptides. Benzodiazole amino acids retain the binding capabilities of bioactive peptides and display excellent signal‐to‐background ratios. Furthermore, we have demonstrated their application in peptide‐PAINT imaging of postsynaptic density protein‐95 nanoclusters in the synaptosomes from mouse brain tissues.

28 February 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
ACAlexandre Chappard
Alexandre Chappard
CLCraig Leighton
Craig Leighton
RSRebecca S. Saleeb
Rebecca S. Saleeb
KJKiani Jeacock
Kiani Jeacock
SBSarah R. Ball
Sarah R. Ball
MHMathew Horrocks
Mathew Horrocks
Protein misfolding and aggregation into oligomeric and fibrillar structures is a common feature of many neurogenerative disorders. Single‐molecule techniques have enabled characterization of these lowly abundant, highly heterogeneous protein aggregates, previously inaccessible using ensemble averaging techniques. However, they usually rely on the use of recombinantly‐expressed labeled protein, or on the addition of amyloid stains that are not protein‐specific. To circumvent these challenges, we have made use of a high affinity antibody labeled with orthogonal fluorophores combined with fast‐flow microfluidics and single‐molecule confocal microscopy to specifically detect α‐synuclein, the protein associated with Parkinson's disease. We used this approach to determine the number and size of α‐synuclein aggregates down to picomolar concentrations in biologically relevant samples.

17 November 2023 in Science Advances
Verified
Journal Article
Open access
RSRebecca S. Saleeb
Rebecca S. Saleeb
CLCraig Leighton
Craig Leighton
JLJi-Eun Lee
Ji-Eun Lee
JOJudi O’sHaughnessy
Judi O’sHaughnessy
KJKiani Jeacock
Kiani Jeacock
MHMathew Horrocks
Mathew Horrocks
Protein misfolding and aggregation is a characteristic of many neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease. The oligomers generated during aggregation are likely involved in disease pathogenesis and present promising biomarker candidates. However, owing to their small size and low concentration, specific tools to quantify and characterize aggregates in complex biological samples are still lacking. Here, we present single-molecule two-color aggregate pulldown (STAPull), which overcomes this challenge by probing immobilized proteins using orthogonally labeled detection antibodies. By analyzing colocalized signals, we can eliminate monomeric protein and specifically quantify aggregated proteins. Using the aggregation-prone alpha-synuclein protein as a model, we demonstrate that this approach can specifically detect aggregates with a limit of detection of 5 picomolar. Furthermore, we show that STAPull can be used in a range of samples, including human biofluids. STAPull is applicable to protein aggregates from a variety of disorders and will aid in the identification of biomarkers that are crucial in the effort to diagnose these diseases.

17 August 2025 in Small Methods
Verified
Journal Article
Open access
TZTianxiao Zhao
Tianxiao Zhao
NPNoelia Pelegrina‐Hidalgo
Noelia Pelegrina‐Hidalgo
DEDaniel C. Edwards
Daniel C. Edwards
KBKrzysztof M. Bąk
Krzysztof M. Bąk
UKUtsa Karmakar
Utsa Karmakar
MHMathew Horrocks
Mathew Horrocks
Extracellular vesicles (EVs) are small, membrane‐bound particles released by cells into the extracellular environment. They play a pivotal role in cell communication and have recently gained prominence as biomarkers. However, their low abundance and high heterogeneity challenge their accurate characterization using conventional approaches. To enable the specific detection of individual EVs, EV‐specific antibodies labeled with two different fluorophores are coupled with fast‐flow microfluidics and single‐molecule confocal microscopy. This allows for the determine the concentration of EVs down to sub‐femtomolar levels (≈10 7 EVs mL −1 ), and the approach demonstrates the capacity to detect EVs even in the presence of other lipid vesicles. The ability to quantify EVs in serum and plasma samples, without the need for purification is highlighted. Furthermore, the yield of EVs extracted from both serum and plasma is compared using ultracentrifugation and various size exclusion chromatography approaches. Overall, the method offers a highly specific, sensitive and easy‐to‐use solution for characterizing EVs from different sources.

28 August 2025 in bioRxiv
Verified
Preprint
Open access
JEJames R. Evans
James R. Evans
MGMelissa Grant-Peters
Melissa Grant-Peters
JBJoseph S. Beckwith
Joseph S. Beckwith
CTChristina E. Toomey
Christina E. Toomey
RPRebeka Popovic
Rebeka Popovic
SGSonia Gandhi
Sonia Gandhi
SUMMARY: Parkinson’s disease (PD) is characterised by insoluble α-synuclein (αSyn) aggregates in Lewy bodies (LBs) within the substantia nigra, with cortical pathology appearing as the disease progresses. Late-stage LB deposition, cellular stress, and neuronal loss obscure disease-driving events, we therefore performed multi-regional transcriptomic and aggregate profiling in early-midstage PD brains (Braak 3–4), where cortical regions are pathologically unaffected. We report neuroimmune activation as an early PD feature, characterised by the expansion of a high- SNCA -expressing microglial state. This robust immune signature occurs prior to LB formation, but is associated with oligomeric αSyn within cortical microglia. In hiPSC-derived microglia, both endogenous αSyn oligomerisation, and exogenous oligomer uptake, trigger transcriptional reprogramming, characterised by interferon-driven inflammation, antigen presentation, and mitochondrial suppression, closely mirroring the early PD brain. These findings describe mechanisms by which αSyn oligomerisation potently initiates early neuroinflammation, highlighting a critical interplay between proteinopathy and immune activation at the earliest stages of disease.

28 February 2023 in Angewandte Chemie
Verified
Journal Article
Open access
ACAlexandre Chappard
Alexandre Chappard
CLCraig Leighton
Craig Leighton
RSRebecca S. Saleeb
Rebecca S. Saleeb
KJKiani Jeacock
Kiani Jeacock
SBSarah R. Ball
Sarah R. Ball
MHMathew Horrocks
Mathew Horrocks
Protein misfolding and aggregation into oligomeric and fibrillar structures is a common feature of many neurogenerative disorders. Single‐molecule techniques have enabled characterization of these lowly abundant, highly heterogeneous protein aggregates, previously inaccessible using ensemble averaging techniques. However, they usually rely on the use of recombinantly‐expressed labeled protein, or on the addition of amyloid stains that are not protein‐specific. To circumvent these challenges, we have made use of a high affinity antibody labeled with orthogonal fluorophores combined with fast‐flow microfluidics and single‐molecule confocal microscopy to specifically detect α‐synuclein, the protein associated with Parkinson's disease. We used this approach to determine the number and size of α‐synuclein aggregates down to picomolar concentrations in biologically relevant samples.